Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | -16 |
| Ticker | VXRT |
| Latest Price | 0.43 USD as of close on 03-Jul-2025 |
| 3 Month price range | 0.31 to 0.70 USD |
| Market Capitalisation | 97.45Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California. See More ... |
| Company URL | https://vaxart.com |
| See Darwins Full Analysis for Vaxart Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Vaxart Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -8 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -3 |
| Flow | Institutional, Fund and Insider buying and selling. | +1 |
| Models | Forecast models. | -6 |
There are 2 live alerts for Vaxart Inc.
There are 6 peers of Vaxart Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc (CPRX) | Biotechnology | -15.1 | +23 |
| Elevation Oncology Inc (ELEV) | Biotechnology | +27.5 | -5 |
| Revelation Biosciences Inc (REVB) | Biotechnology | -14.1 | -19 |
| Synaptogenix Inc (SNPX) | Biotechnology | +226.1 | +1 |
| TG Therapeutics Inc (TGTX) | Biotechnology | -0.9 | +34 |
| Windtree Therapeutics Inc (WINT) | Biotechnology | +38.7 | -21 |
To see complete information on Vaxart Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |